S100A10 and Its Binding Partners in Depression and Antidepressant Actions

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2022 Sep 1

PMID 36046712

Authors

Michelle X Chen

Yong-Seok Oh

Yong Kim

Affiliations

Soon will be listed here.

Abstract

S100A10 (p11) is an emerging player in the neurobiology of depression and antidepressant actions. p11 was initially thought to be a modulator of serotonin receptor (5-HTR) trafficking and serotonergic transmission, though newly identified binding partners of p11 and neurobiological studies of these proteins have shed light on multifunctional roles for p11 in the regulation of glutamatergic transmission, calcium signaling and nuclear events related to chromatin remodeling, histone modification, and gene transcription. This review article focuses on direct binding partners of p11 in the brain including 5-HTRs, mGluR5, annexin A2, Ahnak, Smarca3, and Supt6h, as well as their roles in neuronal function, particularly in the context of depressive-like behavior as well as behavioral effects of antidepressant drug treatments in mice. In addition, we discuss neurobiological insights from recently uncovered p11 pathways in multiple types of neurons and non-neuronal cells and cast major remaining questions for future studies.

Citing Articles

Muscle Cathepsin B treatment improves behavioral and neurogenic deficits in a mouse model of Alzheimer's Disease.

Pinto A, Haytural H, Loss C, Loss C, Alvarez C, Ertas A bioRxiv. 2025; .

PMID: 39896474 PMC: 11785056. DOI: 10.1101/2025.01.20.633414.

Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.

Jaber M, Kahwaji H, Nasr S, Baz R, Kim Y, Fakhoury M Adv Exp Med Biol. 2024; 1456:359-378.

PMID: 39261438 DOI: 10.1007/978-981-97-4402-2_18.

A proximity proteomics pipeline with improved reproducibility and throughput.

Zhong X, Li Q, Polacco B, Patil T, Marley A, Foussard H Mol Syst Biol. 2024; 20(8):952-971.

PMID: 38951684 PMC: 11297269. DOI: 10.1038/s44320-024-00049-2.

Ahnak in the prefrontal cortex mediates behavioral correlates of stress resilience and rapid antidepressant action in mice.

Bhatti D, Jin J, Cheng J, McCabe K, Lee K, Berdasco C Front Mol Neurosci. 2024; 17:1350716.

PMID: 38828281 PMC: 11140847. DOI: 10.3389/fnmol.2024.1350716.

Recent Advances in Molecular and Cellular Functions of S100A10.

Okura G, Bharadwaj A, Waisman D Biomolecules. 2023; 13(10).

PMID: 37892132 PMC: 10604489. DOI: 10.3390/biom13101450.

References

Lee K, Westin L, Kim J, Chang J, Oh Y, Amreen B . Alteration by p11 of mGluR5 localization regulates depression-like behaviors. Mol Psychiatry. 2015; 20(12):1546-56. PMC: 4907335. DOI: 10.1038/mp.2015.132. View

Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Arango-Llievano M . Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med. 2010; 2(54):54ra76. PMC: 3026098. DOI: 10.1126/scitranslmed.3001079. View

Liu Y, Blackwood D, Caesar S, de Geus E, Farmer A, Ferreira M . Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry. 2010; 16(1):2-4. PMC: 3883627. DOI: 10.1038/mp.2009.107. View

Medrihan L, Sagi Y, Inde Z, Krupa O, Daniels C, Peyrache A . Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus. Neuron. 2017; 95(3):564-576.e4. DOI: 10.1016/j.neuron.2017.06.044. View

Ettman C, Abdalla S, Cohen G, Sampson L, Vivier P, Galea S . Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2020; 3(9):e2019686. PMC: 7489837. DOI: 10.1001/jamanetworkopen.2020.19686. View

Warner-Schmidt J, Chen E, Zhang X, Marshall J, Morozov A, Svenningsson P . A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry. 2010; 68(6):528-35. PMC: 2929288. DOI: 10.1016/j.biopsych.2010.04.029. View

Naja W, Aoun M, El Khoury E, Abdallah F, Haddad R . Prevalence of depression in Syrian refugees and the influence of religiosity. Compr Psychiatry. 2016; 68:78-85. DOI: 10.1016/j.comppsych.2016.04.002. View

Lokman N, Ween M, Oehler M, Ricciardelli C . The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 2011; 4(2):199-208. PMC: 3170418. DOI: 10.1007/s12307-011-0064-9. View

Lee I, Sohn M, Lim H, Yoon S, Oh H, Shin S . Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene. 2014; 33(38):4675-84. PMC: 4180639. DOI: 10.1038/onc.2014.69. View

10.

Nestler E, Barrot M, DiLeone R, Eisch A, Gold S, Monteggia L . Neurobiology of depression. Neuron. 2002; 34(1):13-25. DOI: 10.1016/s0896-6273(02)00653-0. View

11.

Kwon M, Macleod T, Zhang Y, Waisman D . S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci. 2004; 10:300-25. DOI: 10.2741/1529. View

12.

Murphy S, de Cates A, Gillespie A, Godlewska B, Scaife J, Wright L . Translating the promise of 5HT receptor agonists for the treatment of depression. Psychol Med. 2020; 51(7):1111-1120. PMC: 8188527. DOI: 10.1017/S0033291720000604. View

13.

Li X, Aida J, Hikichi H, Kondo K, Kawachi I . Association of Postdisaster Depression and Posttraumatic Stress Disorder With Mortality Among Older Disaster Survivors of the 2011 Great East Japan Earthquake and Tsunami. JAMA Netw Open. 2019; 2(12):e1917550. PMC: 6991206. DOI: 10.1001/jamanetworkopen.2019.17550. View

14.

Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, Pilc A . mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants. Neuropharmacology. 2012; 66:40-52. DOI: 10.1016/j.neuropharm.2012.05.022. View

15.

Sargin D, Chottekalapanda R, Perit K, Yao V, Chu D, Sparks D . Mapping the physiological and molecular markers of stress and SSRI antidepressant treatment in S100a10 corticostriatal neurons. Mol Psychiatry. 2019; 25(5):1112-1129. PMC: 7031043. DOI: 10.1038/s41380-019-0473-6. View

16.

Nautiyal K, Tritschler L, Ahmari S, David D, Gardier A, Hen R . A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors. Neuropsychopharmacology. 2016; 41(12):2941-2950. PMC: 5061886. DOI: 10.1038/npp.2016.109. View

17.

Jin J, Bhatti D, Lee K, Medrihan L, Cheng J, Wei J . Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behavior. Mol Psychiatry. 2019; 25(5):1035-1049. PMC: 6692256. DOI: 10.1038/s41380-019-0371-y. View

18.

Haase H . Ahnak, a new player in beta-adrenergic regulation of the cardiac L-type Ca2+ channel. Cardiovasc Res. 2006; 73(1):19-25. DOI: 10.1016/j.cardiores.2006.09.001. View

19.

Otte C, Gold S, Penninx B, Pariante C, Etkin A, Fava M . Major depressive disorder. Nat Rev Dis Primers. 2016; 2:16065. DOI: 10.1038/nrdp.2016.65. View

20.

Green E, Grozeva D, Jones I, Jones L, Kirov G, Caesar S . The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry. 2009; 15(10):1016-22. PMC: 3011210. DOI: 10.1038/mp.2009.49. View